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A B S T R A C T   
Background: Low-frequency oscillations (LFO) detected in the internal globus pallidus of dystonia patients have 
been identified as a physiomarker for adaptive Deep Brain Stimulation (aDBS), since LFO correlate with dystonic 
symptoms and are rapidly suppressed by continuous DBS (cDBS). However, it is as yet unclear how LFO should 
be incorporated as feedback for aDBS. 
Objectives: to test the acute effects of aDBS, using the amplitude of short-lived LFO-bursts to titrate stimulation, to 
explore the immediate effects of cDBS on LFO-modulation and dystonic symptoms, and to investigate whether a 
difference in the resting-state LFO is present between DBS-naïve patients and patients with chronic DBS. 
Methods: seven patients were assessed during either DBS-implantation (n = 2) or battery replacement surgery (n 
= 5), and pseudorandomized in three conditions: no stimulation, cDBS, and aDBS. Additionally, resting-state 
LFP-recordings from patients undergoing battery replacement were compared to those obtained during DBS- 
implantation; LFP-recordings from a previous cohort of six dystonia patients undergoing DBS-implantation 
were incorporated into this analysis (total n = 8 newly implanted patients). 
Results: we corroborated that a mild LFO-suppression rapidly occurs during cDBS. However, no acute changes in 
clinical symptoms were observed after cDBS or aDBS. Remarkably, we observed that resting-state LFO were 
significantly lower in patients who had been effectively treated with chronic cDBS compared to those of newly 
implanted patients, even when stimulation was suspended. 
Conclusions: our results indicate that LFO-suppression in dystonia, similar to symptom response to cDBS, might be 
gradual, and remain after stimulation is suspended. Therefore, tracking gradual changes in LFO may be required 
for aDBS implementation.   
1. Introduction 
Conventional, continuous deep brain stimulation (cDBS) of the in-
ternal globus pallidus (GPi) is an advanced treatment for dystonia. 
Although cDBS is efficacious, it still has some drawbacks. It takes 
months to find the right programming settings, as dystonia reacts rela-
tively slowly to stimulation [1]. Also, its clinical benefits can be limited, 
and stimulation-dependent side-effects, such as parkinsonism and 
dysarthria [1,2], can occur. In order to minimize the impact of 
stimulation-induced side-effects, while preserving the beneficial effect 
of stimulation, the development of adaptive DBS (aDBS) for dystonia has 
been proposed [3]. aDBS aims to reduce the total amount of stimulation 
by titrating stimulation up or down, according to the presence of dys-
tonic symptoms. In order to predict whether symptoms are present, 
aDBS requires electrophysiological biomarkers (physiomarkers) that are 
able to reflect the clinical state of the patients [4]. Up to now, the most 
promising physiomarker for dystonia is the magnitude of low-frequency 
oscillations (LFO; 4–12 Hz) embedded in the local field potential (LFP) 
activity of the GPi. Those oscillations are increased in dystonia [5], and 
correlate with the severity of dystonic symptoms [4]. However, it is as 
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yet unclear how LFO should be incorporated as a feedback signal for 
aDBS, given that these oscillations present distinctive characteristics at 
different timescales. On a millisecond timescale, it has been observed 
that LFO occur in the form of short-lived bursts, and that the amplitude 
of those bursts is increased in dystonia patients [6]. On a 
second-to-minute timescale, it has been shown that GPi-LFO power gets 
swiftly suppressed in dystonia patients during cDBS, predominantly in 
patients with phasic symptoms [7]. However, it is still unclear whether a 
fast LFO-suppression is synchronous with a reduction in dystonic 
symptoms during stimulation. On a longer timescale (minutes to hours 
or more), it has been observed that slow increments in background 
LFO-power take place in dystonia patients chronically treated with 
cDBS, after stimulation is suspended [8]. Those increments in LFO are 
proportional to the return of dystonic symptoms caused by switching off 
stimulation, which suggests that not only symptoms, but also LFO are 
chronically suppressed by cDBS. For the aforementioned reasons, aDBS 
could be programmed to respond either to dynamic changes in 
LFO-burst amplitude, to fast changes in LFO-power, or to gradual 
changes in background LFO-power. 
In this study, we explore the effects of delivering stimulation at three 
different timescales in dystonia patients, in order to generate data- 
driven hypotheses about the incorporation of LFO as feedback signal 
in aDBS for dystonia. Firstly, we test the immediate effects of burst- 
based aDBS, in which the amplitude of LFO-bursts is used as feedback 
signal to dynamically titrate stimulation. Secondly, we explore the acute 
effects of cDBS, in order to confirm the presence of a LFO-suppression 
directly after cDBS, and to investigate the relationship between this 
suppression and dystonic symptoms. Lastly, we estimate the chronic 
effects of stimulation on LFO-power, by comparing the recordings of 
DBS-naive patients with those of patients with chronic cDBS. 
2. Methods 
2.1. No-Stimulation, cDBS and aDBS trials 
2.1.1. Patients 
Seven dystonia patients who underwent either DBS implantation (n 
= 2) or battery replacement surgery (n = 5) at the University Medical 
Fig. 1. Characteristics of low-frequency oscillations in dystonia patients across different conditions. 
A) Schematic representation of the stimulation paradigm for aDBS: 1. The electrodes implanted in the internal globus pallidus are connected to the external amplifier 
(not represented here) through externalized extension wires. 2. In this example, recordings are obtained from contacts 0–2, while delivering stimulation from contact 
1. a) LFP bandpass filtered at 3–37 Hz. b) LFP filtered around the low-frequency peak (7 Hz in this example). c) LFP is rectified and smoothed, and an arbitrary 
threshold is set. d) Stimulation is delivered according to the threshold established. 
B) 1. Comparison of normalized PSDs obtained from LFP recordings of dystonia patients without stimulation, before pseudo-randomization (NoStim0) and during 
cDBS. 2. Comparison of mean low-frequency power between NoStim0 and cDBS. 
C) 1. Comparison of normalized PSDs obtained from LFP recordings of dystonia patients without stimulation, before and after pseudo-randomization (NoStim0 and 
NoStim1 conditions). 2. Comparison of mean low-frequency power between NoStim0 and NoStim1. 
D) 1. Comparison of normalized PSDs obtained from LFP recordings of dystonia patients without stimulation, before pseudo-randomization (NoStim0) and during 
aDBS. 2. Comparison of mean low-frequency power between NoStim0 and aDBS. 
E) 1. Comparison of normalized PSDs obtained from LFP recordings of dystonia patients undergoing new DBS implantations (NoStimN) and patients undergoing 
battery replacements (NoStimB). 2. Comparison of mean low-frequency power of patients undergoing new DBS implantations (NoStimN) and battery re-
placements (NoStimB). 
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Center Groningen, the Netherlands, were included in the study. The 
protocol was approved by the local ethical committee; all patients pro-
vided written informed consent. Patients were operated under local 
anesthesia, and anti-dystonic medication was suspended at least 12 h 
before the procedure. 
2.1.2. Recordings 
LFP-recordings were obtained 20–30 min after intraoperative stim-
ulation testing (DBS-implantation) or 20–30 min after DBS was turned 
off (battery replacement). The recording procedure lasted approxi-
mately 15 min, which has been previously described [6]. In brief, the 
extension wires that connect to the DBS leads were exposed and attached 
to a custom-made amplifier (Fig. 1A). This amplifier allows for bilateral 
LFP-recordings, using a bipolar montage from either contacts 0–2 or 
1–3, and can simultaneously provide stimulation from either contacts 1 
or 2, respectively. Bipolar recordings were obtained at a sampling rate of 
2000 Hz, while applying a bandpass filter between 3 and 37 Hz. 
Spike2 software (V.8, Cambridge, United Kingdom) was employed 
for the recordings. For each hemisphere, a baseline recording of 
approximately one minute was obtained from each bipolar contact 
(NoStim0) during rest, and periodograms were calculated for each bi-
polar LFP, in order to identify a low-frequency peak. The contacts 
selected to further record/stimulate for each hemisphere were chosen 
based on the contacts that met the most of these conditions: a) contacts 
that presented the highest low-frequency peak; b) contacts that provided 
a clear LFP signal; c) contacts that were used in the clinical care (in 
patients with chronic DBS). 
After selecting the contacts, patients were pseudo-randomized into 
three balanced conditions: no stimulation (NoStim1), cDBS, and aDBS. 
Conditions were measured sequentially in a crossover fashion and lasted 
around two to four minutes each. During aDBS, LFPs were filtered 
around the frequency of the highest low-frequency peak (±3 Hz), and 
the filtered signal was rectified. A threshold for stimulation was set at 
roughly 50% of the maximum amplitude of the smoothed-rectified LFP- 
envelope (Fig. 1 A.2). Similar settings were applied during cDBS and 
aDBS conditions (frequency 135 Hz, pulse width 60 μs). The applied 
amplitude was the maximum voltage tolerated that did not corrupt the 
recordings and/or that approached the voltage used for cDBS in the 
clinical practice. In five of the seven patients, a short version of the 
Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and/or the Tor-
onto Western Spasmodic Torticollis Rating Scale (TWSTRS) was video- 
recorded during each condition, using the facial and cervical sub-
domains. Afterwards, the aDBS amplifier was disconnected and the 
surgical procedure continued as usual. Videos were blindly assessed by 
an independent expert in movement disorders. 
2.1.3. Signal processing 
Selected LFPs were processed offline using a custom-made script in 
MATLAB (ver. 2018b, Natick MA, USA), and the FieldTrip-toolbox 
(University Nijmegen, The Netherlands [9]). Bipolar recordings were 
filtered at 4–35 Hz. Segments of approximately 2 min were chosen from 
each condition. Jump artefacts were attenuated using a wavelet denoise 
filter, and contamination occurring at subharmonic frequencies of 
stimulation or line noise was removed using the DBSFILT-toolbox, by 
interpolation with neighboring frequencies (Université Lyon, France 
[10]). 
Immediate changes in LFO-power were explored by obtaining 
periodograms for each LFP in the NoStim0, NoStim1, cDBS and aDBS 
conditions, using a multitaper window with ±0.5Hz smoothing and 
0.5Hz resolution. Each periodogram was normalized by dividing it by 
the root mean square (RMS) of its total beta power (13–30 Hz), in order 
to attenuate changes in noise floor due to stimulation, while allowing 
variations in LFO among conditions. By using the RMS of the beta power, 
we considered shifts in the whole beta spectrum as a consequence of 
stimulation changes in the noise floor, and changes in frequency peaks 
as a result of physiological effects of stimulation (Supplementary Figure 
1). Mean low-frequency power was obtained from each periodogram. 
2.2. New-implantation and battery-replacement recordings 
LFP-recordings during the NoStim0 condition obtained from patients 
undergoing battery replacement (n = 5) were compared to those 
measured during DBS-implantation (n = 2). To complement the DBS- 
implantation cohort, LFP-recordings from a previous cohort of six dys-
tonia patients obtained during DBS-implantation (described in Ref. [6]) 
were incorporated into the analysis (total n = 8). Previous recordings 
were re-referenced from monopolar to bipolar, using the configuration 
0–2 or 1–3. Channels per hemisphere were selected based on those used 
for stimulation in clinical practice. LFPs were normalized across subjects 
by transforming their amplitude into z-scores. Periodograms were 
derived from those LFPs, and their mean low-frequency power was 
calculated. 
2.3. Statistical analysis 
A repeated-measures ANOVA was performed using the mean low- 
frequency power calculated for the NoStim0, NoStim1, cDBS and 
aDBS conditions. Additionally, due to the exploratory nature of this 
study and the limited power of our pilot sample to detect differences at a 
group comparison level, additional pairwise comparisons were per-
formed between conditions using permutation dependent t-tests. Mean 
low-frequency power between new-implantation and battery- 
replacement patients was compared using permutation independent t- 
tests. BFMDRS and TWSTRS scores were compared among conditions 
using repeated-measures ANOVA and additional explorative pairwise 
dependent t-tests between conditions were performed. All units are re-
ported in means ± standard error of the mean (SEM). 
3. Results 
Patient information is presented in Table 1. Two GPi-LFP-recordings, 
each from a different patient, were discarded due to the presence of 
cardiac artefacts that interfered with aDBS. The group analysis (n = 12) 
among stimulation conditions (NoStim0, NoStim1, cDBS and aDBS) did 
not reach significance [condition: F (3,33) = 2.27; p= 0.097]. Pairwise 
comparisons between conditions showed a mild but significant mean 
low-frequency power suppression during cDBS, compared to NoStim0 
(Fig. 1B) [mean difference: − 0.39 ± 0.17 a.u.; t (11) = − 2.2282; 
p=0.0477]. The rest of the pairwise comparisons were not significant 
(Fig. 1C–D, Supplementary Table 1). All patients tolerated aDBS at 
similar voltages used for cDBS. The total amount of stimulation during 
aDBS was 43.05 ± 16.8% of that during cDBS. No acute changes in 
BFMDRS and TWSTRS scores were observed among conditions (Sup-
plementary Table 2-4) [BFMDRS-condition F (2,8) = 2.25; p=0.1678; 
TWSTRS-condition F (2,6) = 1; p=0.421], and pairwise comparisons 
were not significant. 
Mean low-frequency power in patients with chronic DBS (5.73 ×
10− 4±9.24 × 10− 5 z-scores) was significantly lower to that of DBS-naive 
patients (9.03 × 10− 4±9.24 × 10− 5 z-scores, Fig. 1D) [t (22) = 2.4635, 
p=0.0221]. 
4. Discussion 
In this study, we explored the effects of delivering stimulation at 
three different timescales in dystonia patients. Firstly, we observed that 
aDBS based on LFO-bursts did not lead to an acute change in either LFO- 
power or dystonic symptoms. Given the delayed response of dystonia to 
stimulation [1], it is possible that fast LFO-components are not able to 
directly reflect the clinical dystonic state. However, the long-term effects 
of targeting LFO-bursts still need to be explored. Secondly, we tested the 
acute effects of cDBS on LFO-power and dystonic symptoms. We 
confirmed that cDBS can swiftly suppress aberrant GPi-LFO [7]. This 





Clinical details of patients with dystonia included in this pilot study.  












DBS parametersc Channels used for 
recording 
Adaptive Deep Brain Stimulation patients 
Dys aDBS- 
GPi 1 
65 F Blepharospasm and oromandibular 
dystonia (Meige’s syndrome) 
9 5 Battery 
replacement 
Botulinum toxin every 
10 weeks 
22/13.5 14/9 L: 0-/C+; 1.5 V; 80 
Hz; 300 μs 
R: − 3/C+; 2.0 V; 60 





64 M Segmental dystonia + Parkinson’s 
disease 
4 0 New 
implantation 
Botulinum toxin every 2 
months 
8/5 19/18 L: 0-/C+; 3.5 V; 135 
Hz; 90 μs 
R: − 2/C+; 3.5 V; 135 





55 M Segmental dystonia (torticollis) 5 2 Battery 
replacement 
Clonazepam 23/14.25  L: − 0/C+; 3.8 V; 135 
Hz; 90 μs 
R: − 0/C+; 3.7 V; 135 





69 F Blepharospasm and oromandibular 
dystonia (Meige’s syndrome) 
4 0 New 
implantation 
Oxazepam 24/24 17/16 L: 0-/3+; 3.0 V; 135 
Hz; 60 μs 
R: 0-/3+; 3.0 V; 135 









9/6.5 19/16 L: − 2/C+; 5.0 V; 130 
Hz; 90 μs 
R: − 2/C+; 5.0 V; 130 





67 F Oromandibular dystonia 9 3 Battery 
replacement 
Clonazepam 17/18.25  L: − 2/C+; 3.5 V; 130 
Hz; 120 μs 
R: − 2/C+; 3.5 V; 130 










63.75/44.75  L: − 0/1+; 4.0 V; 130 
Hz; 120 μs 
R: − 0/1+; 3.5 V; 130 
Hz; 120 μs 
L: 1-3 
R: 0-2 
Previous cohort dystonia patients 
Dys- GPi 1 47 M Generalized (secondary) + spastic 
hemiparesis 
11 0 New 
implantation 
Lorazepam 49/53  L: − 1/C+; 2.2 V; 
135 Hz; 90 μs 
R: − 0/C+; 2.2 V; 
135 Hz; 90 μs 
L: 0-2 
R: 0-2 
Dys-GPi 2 52 M Segmental dystonia (torticollis) 3 0 New 
implantation 
Clonazepam 23/14.25  L: − 0/C+; 3.8 V; 135 
Hz; 90 μs 
R: − 0/C+; 3.7 V; 135 
Hz; 90 μs 
L: 0-2 
R: 0-2 
Dys- GPi 3 52 F Segmental dystonia (Myoclonus- 
dystonia) 
33 0 New 
implantation 
Propranolol, zolpidem 25.25/12 22.5/17.5 L: − 1/C+; 3.2 V; 130 
Hz; 60 μs 
R: − 1/C+; 3.1 V; 130 
Hz; 60 μs 
L: 0-2 
R: 0-2 
Dys- GPi 4 63 M Cervical dystonia 20 0 New 
implantation 
Clonazepam 19.5/11.25 16.5/13.5 L: − 0/1+; 3.6 V; 130 
Hz; 60 μs 
R: − 0/1+; 3.6 V; 130 
Hz; 60 μs 
L: 0-2 
R: 0-2 
Dys- GPi 5 63 M Segmental dystonia (torticollis and 
oromandibular) + Holmes tremor 
63 0 New 
implantation 
Clonazepam 13.75/5 20/8.5 L: − 1/C+; 3.4 V; 180 
Hz; 120 μs 




Dys- GPi 6 65 F Segmental dystonia (torticollis) 12 0 New 
implantation 
– 15.25/12 22/13 L: − 0/C+; 3.2 V; 135 
Hz; 90 μs 
R: − 0/C+; 2.7 V; 135 
Hz; 90 μs 
L: 0-2 
R: 0-2 
a Years in which patients have been treated with DBS at the moment of battery replacement. bPost-operative scores were obtained one year after DBS treatment. c Parameters used for cDBS in the clinical setting at the 
moment of battery replacement, or one year after implantation for patients measured during DBS-implantation. d This patient was included due to the presence of prominent segmental dystonia, which led to choose the 
internal globus pallidus as the DBS target, instead of the subthalamic nucleus. e This patient is the same as Dys-GPi 2. 
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result supports the hypothesis that DBS modulates pathological hyper-
synchronization in the motor network [5]. However, this acute 
LFO-suppression is initially subtle and might not be followed by a direct 
change in symptom severity. Lastly, we observed that the LFO of patients 
who had been chronically treated with cDBS were considerably lower 
than those of DBS-naïve patients, even when stimulation was suspended. 
From all the patients treated with chronic cDBS, most of them (4/5) 
presented more than the minimal clinically important improvement in 
dystonic symptoms [11] one year after DBS implantation. Since LFO are 
correlated with the severity of dystonic symptoms [4], it is possible that 
the LFO-suppression that takes place during cDBS occurs in a gradual 
manner, parallel to the gradual reduction in dystonic symptoms 
observed after cDBS is switched on. 
The re-emergence of LFO after cDBS is suspended also occurs in a 
gradual manner [8]. Barow et al. showed that LFO remain suppressed 
shortly after stimulation is applied [7]. In our study, we observed that 
the OFF LFO-power of patients measured after pseudo-randomization 
(NoStim1) was slightly lower than before pseudo-randomization (NoS-
tim0, Fig. 1C). This can be explained by the fact that in some patients the 
cDBS condition preceded the NoStim1 condition. This poststimulation 
effect becomes more apparent when chronic stimulation is suspended, 
since the LFO of dystonia patients increase only gradually over a period 
of several hours, if symptoms increase accordingly [8]. Therefore, 
stimulation algorithms designed to track gradual changes in oscillatory 
power [12] can be tested in aDBS for dystonia (Supplementary Figure 2). 
4.1. Limitations 
The results obtained are preliminary, since a small patient sample 
was included, and only the acute effects of aDBS were explored. Similar 
to other studies involving LFP-recordings in dystonia, the patient group 
included is heterogeneous. Nevertheless, dystonic symptoms and 
prominent LFO were present in all patients. Prospective studies are 
required to explore the chronic within-subjects effect of both cDBS and 
aDBS on LFO and dystonic symptoms, in order to corroborate the claims 
provided here. However, the results obtained in this study are useful to 
generate data-driven hypotheses regarding the configuration of future 
aDBS systems for dystonia. 
5. Conclusion 
LFO-suppression in dystonia, similar to symptom response to cDBS, 
might be gradual, and remain after stimulation is suspended. Therefore, 
tracking gradual changes in LFO may be required for aDBS imple-
mentation. Future sensing aDBS devices will allow to explore the tem-
poral relation between chronic LFO-suppression and dystonic symptoms 
[12]. 
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